Cargando…

Critical appraisal of rotigotine transdermal system in management of Parkinson’s disease and restless legs syndrome – patient considerations [Corrigendum]

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2016
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6053086/ https://www.ncbi.nlm.nih.gov/pubmed/30050364 http://dx.doi.org/10.2147/DNND.S94117

Ejemplares similares

Critical appraisal of rotigotine transdermal system in management of Parkinson’s disease and restless legs syndrome – patient considerations
por: Kesayan, Tigran, et al.
Publicado: (2015)

Transdermal rotigotine for the perioperative management of restless legs syndrome
por: Högl, Birgit, et al.
Publicado: (2012)

An Update on Pharmacological, Pharmacokinetic Properties and Drug–Drug Interactions of Rotigotine Transdermal System in Parkinson’s Disease and Restless Legs Syndrome
por: Elshoff, Jan-Peer, et al.
Publicado: (2015)

Restless legs syndrome: differential diagnosis and management with rotigotine
por: Merlino, Giovanni, et al.
Publicado: (2009)

Treatment of moderate to severe restless legs syndrome: 2-year safety and efficacy of rotigotine transdermal patch
por: Högl, Birgit, et al.
Publicado: (2010)

Transdermal rotigotine for the perioperative management of Parkinson’s disease
por: Wüllner, Ullrich, et al.
Publicado: (2010)

Rotigotine's effect on PLM-associated blood pressure elevations in restless legs syndrome: An RCT
por: Bauer, Axel, et al.
Publicado: (2016)

Behavioral and Neurophysiological Effects of Transdermal Rotigotine in Atypical Parkinsonism
por: Moretti, Davide Vito, et al.
Publicado: (2014)

Restless Legs Syndrome and Leg Motor Restlessness in Parkinson's Disease
por: Suzuki, Keisuke, et al.
Publicado: (2015)

Rotigotine transdermal system: a short review
por: Bunten, Sabine, et al.
Publicado: (2006)

Transdermal rotigotine patch in Parkinson’s disease with a history of intestinal operation
por: Ogawa, Takashi, et al.
Publicado: (2018)

Rotigotine transdermal patch and sleep in Parkinson’s disease: where are we now?
por: Rosa-Grilo, Miguel, et al.
Publicado: (2017)

Restless Legs Syndrome in Parkinson’s Disease
por: Diaconu, Ştefania, et al.
Publicado: (2023)

Overnight switch from ropinirole to transdermal rotigotine patch in patients with Parkinson disease
por: Kim, Han-Joon, et al.
Publicado: (2011)

Rotigotine Transdermal Patch in Parkinson’s Disease: A Systematic Review and Meta-Analysis
por: Zhou, Chang-Qing, et al.
Publicado: (2013)

Evaluation of rotigotine transdermal patch for the treatment of apathy and motor symptoms in Parkinson’s disease
por: Hauser, Robert A, et al.
Publicado: (2016)

Rotigotine suppresses sleep-related muscle activity augmented by injection of dialysis patients’ sera in a mouse model of restless legs syndrome
por: Muramatsu, Kazuhiro, et al.
Publicado: (2019)

Rotigotine transdermal system as add-on to oral dopamine agonist in advanced Parkinson’s disease: an open-label study
por: Kim, Jong-Min, et al.
Publicado: (2015)

Cardiac resynchronization therapy pacemaker: critical appraisal of the adaptive CRT-P device [Corrigendum]
Publicado: (2016)

Istradefylline for Restless Legs Syndrome Associated with Parkinson’s Disease
por: Nuermaimaiti, Maierdanjiang, et al.
Publicado: (2018)

Rotigotine transdermal system and evaluation of pain in patients with Parkinson’s disease: a post hoc analysis of the RECOVER study
por: Kassubek, Jan, et al.
Publicado: (2014)

A Study for Expanding Application Sites for Rotigotine Transdermal Patch
por: Kujirai, Hitoshi, et al.
Publicado: (2020)

Leukoderma Induced by Rotigotine Patch, a Transdermal Dopamine Agonist
por: Talty, Ronan, et al.
Publicado: (2022)

Corrigendum to “Going for a stroll on lurasidone: Considerations on an atypical case of acute compartment syndrome of both legs” [Heliyon 9(4) (April 2023) e15047]()
por: Bosco, L., et al.
Publicado: (2023)

Transdermal Rotigotine Improves Sleep Fragmentation in Parkinson's Disease: Results of the Multicenter, Prospective SLEEP-FRAM Study
por: Pagonabarraga, Javier, et al.
Publicado: (2015)

Management of Restless Legs Syndrome in Pregnancy and Lactation
por: Jahani Kondori, Marjan, et al.
Publicado: (2020)

Parkinson’s disease managing reversible neurodegeneration [Corrigendum]
Publicado: (2016)

Corrigendum to “Management of endometriosis-related infertility: Considerations and treatment options”
por: Lee, Dayong, et al.
Publicado: (2020)

Rotigotine Transdermal Patch for Motor and Non-motor Parkinson’s Disease: A Review of 12 Years’ Clinical Experience
por: Raeder, Vanessa, et al.
Publicado: (2021)

Efficacy and Safety of Rotigotine Transdermal Patch on Neuropsychiatric Symptoms of Parkinson's Disease: An Updated Meta-Analysis and Systematic Review
por: Yan, Junqiang, et al.
Publicado: (2021)

Restless Legs Syndrome and Its Associated Risk Factors in Parkinson's Disease
por: Azmin, Shahrul, et al.
Publicado: (2013)

Restless Chest Syndrome: A Rare Variant of Restless Legs Syndrome
por: Ishizuka, Kosuke, et al.
Publicado: (2022)

Restless legs syndrome: diagnosis and review of management options
por: Byrne, Ruth, et al.
Publicado: (2006)

Restless legs syndrome: differential diagnosis and management with pramipexole
por: Brindani, Francesca, et al.
Publicado: (2009)

Pharmacokinetics, Safety and Tolerability of Rotigotine Transdermal Patch in Healthy Japanese and Caucasian Subjects
por: Cawello, Willi, et al.
Publicado: (2013)

Amino acid management of Parkinson’s disease: a case study [Corrigendum]
Publicado: (2016)

Migraine and restless legs syndrome: is there an association?
por: Cannon, Paul R., et al.
Publicado: (2011)

Ropinirole for the treatment of restless legs syndrome
por: Kushida, Clete A
Publicado: (2006)

Restless Legs Syndrome: The underrecognised condition
por: Benamer, Hani
Publicado: (2006)

Migraine with aura and restless legs syndrome
por: Larner, Andrew J.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_r7fojclu4iq0kaatv3fotehok5